Bally’s Corporation (NYSE: BALY) eyes evoke plc (LSE: EVOK): why a William Hill deal would reshape UK gambling
Read More Pharma Industry News Dr. Reddy’s Laboratories launches FDA-approved Regadenoson Injection in the US market Dr. Reddy’s Laboratories has launched its FDA-approved generic Regadenoson Injection in the US, offering a cost-effective alternative to Lexiscan for cardiac imaging. byPallavi MadhirajuMay 7, 2023